CA9 and breast cancer: In particular, CAIX appears to be highly expressed in breast cancer and has relatively low expression in normal tissues [37–40] and expression is located on the extracellular surface of cell membranes, allowing for efficient targeting by monoclonal antibodies or small molecule inhibitors.